Related Experiment Videos
Mast cell profile in prostatic lesions
T Amir1, R R Pai, C V Raghuveer
1Pathology Department, Kasturba Medical College, Mangalore.
Indian Journal of Medical Sciences
|April 28, 1999
Summary
Mast cells, crucial immune cells, show varied distribution in prostate tissues. Their counts differ significantly between benign conditions like nodular hyperplasia and prostate cancer, suggesting diagnostic potential.
Area of Science:
- Urology
- Pathology
- Immunology
Background:
- Mast cells play roles in inflammation and tissue remodeling.
- Their specific distribution in various prostate pathologies is not well-characterized.
Purpose of the Study:
- To analyze mast cell distribution in common prostate lesions.
- To investigate the potential of mast cell counts in differentiating benign from malignant prostatic conditions.
Main Methods:
- Analysis of 173 consecutive prostatic biopsy specimens.
- Categorization into nodular hyperplasia (with/without prostatitis), prostatic intraepithelial neoplasia, and adenocarcinoma.
- Toluidine blue staining to quantify mast cells per square millimeter.
Main Results:
- Significantly higher mast cell counts in fibromuscular stroma versus glandular areas in nodular hyperplasia.
- Very significantly lower mast cell counts in inflammatory lesions, likely due to degranulation.
- Absence or low mast cell counts observed in adenocarcinoma, with some concentration around tumors.
Conclusions:
- Mast cell distribution varies considerably across different prostatic lesions.
- Low mast cell counts in adenocarcinoma warrant further investigation for diagnostic utility.
- Further studies are needed to evaluate mast cell counts for differentiating malignant from benign and atypical prostate conditions.